NM_022124.6:c.-35_-31delAGGCG

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_022124.6(CDH23):​c.-35_-31delAGGCG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 172,870 control chromosomes in the GnomAD database, including 1,393 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1313 hom., cov: 0)
Exomes 𝑓: 0.067 ( 80 hom. )

Consequence

CDH23
NM_022124.6 5_prime_UTR

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.67

Publications

2 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
CDH23 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 12
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Usher syndrome type 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Usher syndrome type 1D
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 10-71397276-CCGAGG-C is Benign according to our data. Variant chr10-71397276-CCGAGG-C is described in ClinVar as [Likely_benign]. Clinvar id is 300395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.226 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.-35_-31delAGGCG 5_prime_UTR_variant Exon 1 of 70 ENST00000224721.12 NP_071407.4 Q9H251-1Q6P152

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.-35_-31delAGGCG 5_prime_UTR_variant Exon 1 of 70 5 NM_022124.6 ENSP00000224721.9 Q9H251-1

Frequencies

GnomAD3 genomes
AF:
0.109
AC:
16378
AN:
150180
Hom.:
1304
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.230
Gnomad AMI
AF:
0.0437
Gnomad AMR
AF:
0.0722
Gnomad ASJ
AF:
0.0781
Gnomad EAS
AF:
0.0781
Gnomad SAS
AF:
0.0968
Gnomad FIN
AF:
0.0812
Gnomad MID
AF:
0.0955
Gnomad NFE
AF:
0.0537
Gnomad OTH
AF:
0.104
GnomAD2 exomes
AF:
0.0528
AC:
13
AN:
246
AF XY:
0.0493
show subpopulations
Gnomad NFE exome
AF:
0.0513
Gnomad OTH exome
AF:
0.100
GnomAD4 exome
AF:
0.0675
AC:
1524
AN:
22584
Hom.:
80
AF XY:
0.0692
AC XY:
986
AN XY:
14252
show subpopulations
African (AFR)
AF:
0.123
AC:
19
AN:
154
American (AMR)
AF:
0.0714
AC:
4
AN:
56
Ashkenazi Jewish (ASJ)
AF:
0.0652
AC:
21
AN:
322
East Asian (EAS)
AF:
0.0833
AC:
13
AN:
156
South Asian (SAS)
AF:
0.0917
AC:
582
AN:
6350
European-Finnish (FIN)
AF:
0.0754
AC:
96
AN:
1274
Middle Eastern (MID)
AF:
0.159
AC:
82
AN:
516
European-Non Finnish (NFE)
AF:
0.0508
AC:
654
AN:
12876
Other (OTH)
AF:
0.0602
AC:
53
AN:
880
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.109
AC:
16417
AN:
150286
Hom.:
1313
Cov.:
0
AF XY:
0.109
AC XY:
7987
AN XY:
73344
show subpopulations
African (AFR)
AF:
0.230
AC:
9476
AN:
41168
American (AMR)
AF:
0.0720
AC:
1094
AN:
15194
Ashkenazi Jewish (ASJ)
AF:
0.0781
AC:
270
AN:
3456
East Asian (EAS)
AF:
0.0779
AC:
380
AN:
4876
South Asian (SAS)
AF:
0.0957
AC:
459
AN:
4798
European-Finnish (FIN)
AF:
0.0812
AC:
833
AN:
10256
Middle Eastern (MID)
AF:
0.103
AC:
30
AN:
290
European-Non Finnish (NFE)
AF:
0.0537
AC:
3614
AN:
67262
Other (OTH)
AF:
0.106
AC:
222
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
642
1284
1927
2569
3211
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0250
Hom.:
703

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Nov 12, 2017
GeneDx
Significance:Benign
Review Status:flagged submission
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Outside ROI, common in our data set -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Retinitis pigmentosa-deafness syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.7
Mutation Taster
=113/87
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71012280; hg19: chr10-73157033; API